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Abstract
The innate immune response of airway epithelial cells to aeroallergen initiates the development of 
T cell responses that are central to allergic inflammation. Although proteinase allergens induce the 
expression of interleukin 25 we show that epithelial matrix metalloproteinase 7 (MMP7) was 
expressed in asthma and was required for maximal activity of IL-25 in promoting T helper type 2 
cell differentiation. Allergen-challenged Mmp7−/− mice showed reduced airway hyperreactivity, 
allergic inflammatory cytokine production and increased expression of retinal dehydrogenase 
(RALDH)-1. Inhibition of RALDH-1 restored the asthma phenotype in Mmp7−/− mice and 
inhibited lung T regulatory cell responses while exogenous administration of retinoic acid 
attenuated the asthma phenotype. Thus, MMP7 coordinates allergic lung inflammation by 
activating IL-25 while simultaneously inhibiting retinoid-dependent T regulatory cell 
development.
Proximal and distal airway epithelial cells directly communicate with the outside 
environment and thus their response to inhaled allergens could play an integral part in the 
initiation of allergic lung inflammation. Identification of the critical epithelial-derived 
mediators that drive allergic lung responses is at an early stage, but is essential to a complete 
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understanding of the molecular mechanism(s) underlying diseases such as asthma. In prior 
studies, we demonstrated that, upon inhalation, proteinase allergens (e.g. aeroallergens with 
active proteinase property) rapidly induce a powerful inflammatory response that initiates 
the recruitment of allergic immune cells into the lung1,2. While the role of cytokines 
expressed in the airway epithelium in asthma has been extensively studied3,4, the 
mechanism(s) by which allergens initiate airway TH2 cell differentiation is poorly 
understood. Interleukin 25 (IL-25, also known as IL-17E) is a member of the IL-17 family 
of cytokines that is produced primarily in the airway epithelium in response to proteinase 
allergens5,6. Transgenic expression of human and mouse IL-25 induces TH2 immune 
responses marked by pronounced lung eosinophilia, mucus hyperproduction and increased 
expression of IL-4, IL-5, IL-13 and CCL11 (eotaxin 1) in the airway7,8. Neutralization of 
IL-25 by blocking antibodies has been shown to reverse airway hyperreactivity in a mouse 
model of asthma9. Moreover, inability to develop a strong TH2 biased immune response was 
shown in IL-25-deficient mice, which failed to clear gut parasitic infections with 
Nippostrongylus brasiliensis and Trichuris muris10. These studies suggest a critical role for 
epithelial cells in providing the IL-25 signals that may be required for effective TH2 
responses. Although the role of IL-25 in allergic lung disease is well known, a broader 
understanding of how IL-25 interacts with other airway epithelial factors to coordinately 
regulate allergic responses is needed.
Matrix metalloproteinases (MMPs) are zinc-dependent enzymes that are induced in response 
to a large number of stimuli. Although MMPs were originally shown to mediate turnover of 
extracellular matrix molecules, it is now clear that they control diverse biological processes 
unrelated to matrix degradation11. Although the exact role for MMPs in chronic models of 
lung inflammation is debated, it is clear that several members of this family are acutely 
induced either locally or systemically at the onset of allergen challenge12–16. MMP2 and 
MMP9 are not required for development of allergic lung disease, but play key roles in the 
clearance of inflammatory cells from lung parenchyma by establishing the necessary trans-
epithelial chemokine gradients15,16. However, while neither MMP2 nor MMP9 is expressed 
in the airway epithelium17, MMP7 (also known as matrilysin; http://www.signaling-
gateway.org/molecule/query?afcsid=A001477), an epithelial cell specific MMP, is induced 
in the lung and the gut during inflammation18,19. MMP7 has been shown to modify pro-α-
defensin, Fas-L and tumor necrosis factor (TNF) in the gut during defense against enteric 
pathogens, but its role in allergic inflammation has yet to be explored19,20.
In this study, we examined how airway epithelial IL-25 coordinates proteinase-dependent 
allergic lung disease in the context of other potentially relevant airway epithelial-derived 
factors including MMP7. We show that in response to proteinase active allergen or 
recombinant IL-25, mouse airway epithelial cells expressed MMP. Activation of MMP7 was 
critical for IL-25 function because MMP7-cleaved IL-25 enhanced TH2 cell differentiation. 
Furthermore, we show that humans with chronic asthma also expressed MMP7 and IL-25 in 
their distal airspaces and in response to ragweed extract, a potent allergenic stimuli, patients 
with a history of allergy significantly increased secretion of nasal MMP7. In the absence of 
MMP7, mice showed attenuated allergic responses to proteinase allergen challenge and 
enhanced expression of retinal dehydrogenase-1 (RALDH-1), a rate-limiting enzyme for 
retinoic acid production. Moreover Mmp7−/− mice showed an increase in the number of 
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regulatory T cells in the lung parenchyma. Together, these results support a role for MMP7 
as a proinflammatory mediator that specifically enhances the function of IL-25 that is 
necessary for robust TH2 responses. Finally, we demonstrate a tolerogenic mechanism 
initiated by airway epithelial cells in response to proteinase allergen challenge in which 
RALDH-1 is induced to promote immunosuppressive T regulatory cells.
Results
MMP7 mediate increase function of IL-25
We previously showed that MMP2 and MMP9 are not expressed in airway epithelial cells 
following allergen challenge17. In contrast, a fungal-derived proteinase allergen strongly 
enhanced expression of airway epithelial MMP7 (Fig. 1a). Whereas induction of MMP2 and 
MMP9 was IL-13 dependent15, MMP7 induction was independent of IL-13 as equivalent 
induction of MMP7 was observed in allergen-challenged mice deficient in STAT6, the 
principal mediator of IL-13 effects in the lung (data not shown). Because MMP7 is known to 
cleave and activate cytokines in the gut13, we next determined if MMP7 modifies cytokines 
that are critical for initiating allergic lung responses. In addition to IL-25, IL-13 and thymic 
stromal lymphopoietin (TSLP) are critical participants in the molecular pathways underlying 
allergic lung disease5,21. We found that while recombinant (r)IL-13, and rTSLP were not 
substrates for activated MMP7, under the same conditions rIL-25 was cleaved at multiple 
sites (Fig. 1b, Supplementary Table 1 and Supplementary Fig. 1 online). To determine the 
functional activity of cleaved IL-25, we examined the response of naive spleen and lymph 
node cells after activation by T cell receptor crosslinking in vitro. We found that the 
presence of MMP7-cleaved rIL-25 (hereafter called rIL-25′C), induced significantly more 
secretion of TH2 cytokines (IL-4, IL-5 and IL-13), than native rIL-25 and showed enhanced 
binding to IL-17RB-Fc fusion protein in vitro (Fig. 1c,d; Supplementary Fig. 2a,b online). 
Indeed, native IL-25 had slight effect on IL-4 secretion, but rIL-25′C enhanced IL-4 
secretion 10-fold, suggesting that the major active form of IL-25 is IL-25′C. No effect of 
rIL-25 or rIL-25′C on induction of interferon-γ (IFN-γ), a canonical TH1 cytokine, was 
seen (Fig. 1c). Collectively these data indicate that IL-25 is a substrate for MMP7 and that 
cleavage of IL-25 by MMP7 is necessary to drive robust TH2 responses.
Attenuated asthma phenotype in Mmp7−/− mice
The increased potency of rIL-25′C in activating TH2 cells in vitro raised the possibility of an 
essential role for MMP7 in mediating allergic inflammation in vivo. To determine this, we 
compared the phenotype of Mmp7−/− with wild-type mice in response to the proteinase 
allergen extracted from fungi (complete aspergillus allergen; CAA), a powerful allergen that 
we have previously used to elicit allergic lung disease in mice1. This airway inflammation 
model is characterized by a predominant eosinophil influx and airway obstruction due to 
enhanced glycoprotein secretion, as well as increased airway hyperactivity to secondary 
challenge with acetylcholine (Ach)22,23. As compared to wild-type mice, Mmp7−/− mice 
immunized with CAA showed reduced airway hyperreactivity (AHR) as assessed by both 
reduction in respiratory system resistance (RRS) in response to multiple Ach doses and an 
increase in the provocative concentration of Ach required to elicit a 200% change in RRS 
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from baseline (PC200). Moreover, Mmp7−/− mice secreted less bronchoalveolar lavage 
(BAL) fluid glycoproteins following CAA challenge (Fig. 2a–c).
Airway eosinophilia was also significantly reduced in Mmp7−/− CAA immunized mice (Fig. 
2d). Because lung parenchymal eosinophil egression into the airways is impaired in 
Mmp2−/− and Mmp9−/− mice15,16, we determined lung parenchymal eosinophil numbers to 
rule out a similar defect in Mmp7−/− animals. Analysis of total number of lung parenchymal 
inflammatory cells showed fewer eosinophils in the lungs of CAA immunized Mmp7−/− as 
compared to wild-type mice (Fig. 2e, Supplementary Fig. 3 online), indicating that the 
decreased cell numbers in the airway was not due to reduced cell trafficking.
We turned next to testing whether MMP7-mediated modification of IL-25 was influential in 
determining allergic lung responses. rIL-25 was given intranasally to wild-type and 
Mmp7−/− mice and eosinophil recruitment was determined. In this assay, rIL-25 alone 
readily induced lung eosinophilia and de novo expression of MMP7 in airway epithelial cells 
of wild-type mice, but significantly fewer eosinophils were enumerated and reduced IL-4 
and IL-5 concentrations were detected in BAL fluid of Mmp7−/− mice (Fig. 2f,g and 
Supplementary Fig. 4 online). Collectively, these findings support the concept that induction 
of MMP7 in response to allergens is critical for enhancing IL-25 function during initiation of 
the allergic immune response.
Mmp7−/− mice exhibit reduced Th2 responses
We next determined if the reduced AHR and BAL inflammatory cells seen in Mmp7−/− mice 
were secondary to decreased TH2 responses in Mmp7−/− mice. As expected, IL-4, IL-5, 
IL-13, IL-6 and TNF concentrations in BAL fluid of CAA-challenged Mmp7−/− mice were 
reduced as compared to wild-type mice (Fig. 3 a–c and Supplementary Fig. 5 online) while 
no significant differences were found in CCL3, IL-9 and IL-1β concentrations (data not 
shown). Consistent with reduced lung eosinophilia, we found a significant decrease in 
CCL11 expression in Mmp7−/− CAA-immunized mice compared to wild-type, but no 
significant differences were detected in CCL7 and CCL17 concentrations (Fig. 3d, and data 
not shown). Further, whole lung analysis of the RNA from immunized Mmp7−/− mice 
revealed reduced expression of Il25 compared to wild-type mice (Fig. 3e), suggesting that in 
addition to proteolytic modification of IL-25, activation and function of MMP7 in the lung is 
required for the transcriptional expression of Il-25 in this model of allergic airway disease.
Increased retinoic acid in allergen challenged Mmp7−/−
To determine additional events that might regulate the airway epithelial response to allergen, 
we performed proteomic analyses of BAL fluid in wild-type and Mmp7−/− mice that were 
immunized with CAA17. Among the proteins that were significantly and differentially 
modulated in Mmp7−/− CAA-immunized mice (Supplementary Table 2 online), we found an 
increase in retinaldehyde dehydrogenase-1 (RALDH-1), (Fig. 4a,b and Supplementary Fig. 
6 online). RALDH-1 is the rate-limiting enzyme for conversion of retinaldehyde to all-trans 
retinoic acid (ATRA) that plays a critical role in maintaining the tolerogenic environment of 
mucosal surfaces24. In support of our proteomic-based discovery of increased RALDH-1, 
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BAL fluid analysis of Mmp7−/− CAA-immunized mice revealed an increase in ATRA 
concentration when compared to similarly treated wild-type mice (Fig. 4c).
Next we determined if increased production of ATRA in the lung of Mmp7−/− mice might 
account, in part, for their attenuated response to allergen. Liposomal ATRA was delivered by 
respiratory aerosol to wild-type mice 1 hour before each immunization with CAA, after 
which lung allergic responses were determined. Compared to vehicle (empty liposome) 
aerosol, mice that received ATRA show an attenuated asthma phenotype as demonstrated by 
reduced total number of cells in BAL fluid, especially eosinophils, and decreased Il25 
mRNA expression (Fig. 4d–f). Consistent with a decrease in inflammatory markers, we also 
detected less CCL11, IL-4 and IL-13, which act downstream of IL-25 signaling (Fig. 4g–i 
and Supplementary Fig. 7 online). These data confirm that ATRA exhibits potent anti-
inflammatory activity when administered to the lung and that this activity can be enhanced 
through the inhibition of Il25 gene expression.
Epithelial RALDH-1 and ATRA induce T regulatory cells
We found that RALDH-1 protein is expressed in airway epithelial cells and alveolar 
macrophages of wild-type and Mmp7−/− mice immunized with CAA (Fig. 5a). Increased 
RALDH-1 expression and ATRA concentration has previously been linked to enhanced 
immune tolerance and increased production of inducible T regulatory cells25. Therefore, we 
determined if increased expression of RALDH-1 acts as a negative regulator in response to 
allergens and can increase the relative abundance of T regulatory cells in the lung of wild-
type and Mmp7−/− mice following immunization with CAA. As compared to naive mice, 
wild-type and Mmp7−/− CAA immunized mice showed an increase in the relative abundance 
of CD25+FoxP3+ T regulatory cells in lungs (Fig. 5b and Supplementary Fig. 8 online). To 
further examine the functional role of RALDH-1 in inducing the production of T regulatory 
cells, we administered citral, an inhibitor of RALDH-1, to mice that were immunized with 
CAA26. Inhibition of retinoic acid synthesis by citral decreased the number of 
CD25+FoxP3+ T regulatory cells in the lung (Fig. 5b and Supplementary Fig. 9 online), 
suggesting a possible role for RALDH-1 and ATRA in the development of this inhibitory 
subset of lung T cells. Moreover, compared to CAA alone, wild-type and Mmp7−/− mice 
immunized with CAA and challenged with citral showed more BAL fluid eosinophils, IL-5 
and CCL11 (Fig. 5c–e and data not shown).
MMP7 expression in response to allergen in human asthma
To address the relevance of MMP7 expression in human asthma, we studied human 
bronchial biopsy specimens from volunteers with and without asthma (non-asthmatic 
controls). Interestingly, while IL-25 was detected in airway epithelia of control and 
asthmatic subjects and therefore appeared to be constitutively present, expression of MMP7 
was exclusively found in the airway of asthmatics (Fig. 6a). Consistent with these findings, 
analysis of nasal washings collected from 7 volunteers with allergic rhinitis 30 min and 5 
hours following intranasal challenge with ragweed (a potent proteinase allergen), showed a 
significant increase in MMP7 secretion in response to ragweed, but not normal saline control 
(Fig. 6b and data not shown). We could not detect secretion of IL-25 in nasal washes. 
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Nonetheless, these data suggest that constitutive IL-25 was activated by inducible expression 
of MMP7 during allergen challenge of the human airway.
Discussion
We have shown how proteinase allergens simultaneously activate pro- and anti-inflammatory 
programs in airway epithelial cells. Allergens enhance expression of MMP7 in airway 
epithelial cells to maximize allergic lung inflammation; conversely, in the absence of MMP7 
mice develop an attenuated asthmatic phenotype. The mechanisms responsible for decreased 
allergic inflammation in Mmp7−/− mice appear to be in part related to reduced expression of 
IL-25 that has been shown to be critical in initiating robust TH2 responses5,7,27,28. We found 
that in addition to modulating Il25 gene expression, MMP7 mediated IL-25 cleavage that 
was required for most of its biological activity in allergic inflammation.
Enhanced expression of MMP family members is a frequent manifestation of active or 
chronic inflammatory process, but the precise role of MMPs in these conditions remains 
poorly understood13. Previous studies have documented that proteinase allergens are capable 
of inducing an innate immune response that further modulates the adaptive immune response 
during allergic inflammation1,2. We show here airway epithelial expression of MMP7 was 
critical for the development of asthma-like disease, a finding that is in sharp contrast to the 
functions MMP2 and MMP9, two gelatinases that are also up regulated in the same model, 
as absence of these enzymes led to exaggerated lung allergic inflammation15–17. Further we 
show that MMP7 was expressed in the distal lung parenchyma of untreated asthmatics, and 
that in response to a proteinase allergen derived from ragweed, MMP7 expression was 
significantly induced. Although secreted amounts of IL-25 under the same conditions were 
below the detection limit of our ELISA assay, we found IL-25 expressed in the distal lung 
space in normal and asthmatic volunteers. Collectively, these findings show the temporal 
relation between exposure to allergens and induction of MMP7 in human allergic disease 
and may implicate activation of IL-25 by MMP7 under allergen-exposed conditions. It is 
important to note that during allergic inflammation many endogenous proteinases including 
members of the serine and cysteine family are abundantly present in the airway as we and 
others have shown1,29. However the unique finding that MMP7 was required for 
amplification of TH2 responses emphasizes the non-redundant roles that MMPs may play in 
the course of inflammation. The specificity of this response was exemplified by the specific 
proteolysis IL-25 by MMP7, but not other allergy-related cytokines such as TSLP and IL-13. 
Similarly, MMP7-mediated proteolytic modification of defensins, apoptotic ligands, and 
cytokines has been shown to play important role in diverse biological functions such as 
innate immunity in the gut to cancer cell metatasis19,30–32. The findings that rIL-25 induced 
expression of lung MMP7 and intranasal administration of rIL-25 to Mmp7−/− mice only 
weakly induced allergic inflammation strongly suggests that bioactivity of IL-25 is largely 
dependent on proteolysis by MMP7. These data further suggest the existence of a feedback 
loop wherein IL-25 upregulates lung MMP7 expression followed by cleavage and activation 
of IL-25 that further enhances both MMP7 expression and allergic lung disease.
Although regulation of gene expression has been studied for other members of the IL-17 
family, little is known about IL-25 regulation12. We found that while little to no RALDH-1 
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was present in the airways of naive mice, in response to a proteinase allergens, this enzyme 
was expressed prominently in the airway epithelial cells of both wild-type and Mmp7−/− 
mice. Based on high throughput proteomic analysis we found excess RALDH-1 enzyme in 
immunized Mmp7−/− mice that was functionally relevant because it resulted in increased 
BAL fluid concentrations of ATRA and reduced allergic inflammation. The role of ATRA in 
the regulation of adaptive immunity, especially TH2 responses, is controversial. For example, 
IL-4-induced eotaxin production, eosinophil lineage commitment, and IL-5R expression 
were all strongly inhibited by addition of ATRA in vitro33,34. Furthermore, retinoic acid in 
the presence of TGF-β1 inhibited STAT6 binding to the Foxp3 promoter and effectively 
inhibited IL-4 signaling in T cells35. In other models of allergic lung disease, deficiency in 
vitamin A resulted in a decrease in muscarinic M2 receptor expression, which resulted in 
increased AHR36. In contrast, intranasal administration of high concentrations of ATRA 
(>1500 μg), failed to alter TH2 responses in another asthma model37 and vitamin A 
deficiency has been shown to attenuate TH2 cytokine production in mice38. In our study, 
allergen challenged mice that received 100 μg of ATRA showed a robust reduction in 
allergic inflammation and attenuation of the asthmatic phenotype. Such divergent findings 
are not surprising because of the known idiosyncrasies of retinoid that can act as hormones 
and depending on the physiological or pharmaceutical context, mediate diverse effects on 
cells of the immune system39.
Previous studies have implicated a role for ATRA in the development and differentiation of 
inducible T regulatory cells, an anti-inflammatory subset of T cells that play a significant 
role in homeostasis of lymphocytes in different organs40. In particular, dendritic cells in the 
lamina propria were found to provide ATRA that was critical for differentiation and homing 
of T regulatory cells to the intestinal mucosa41,42. Although we did not identify the cellular 
origin of ATRA, we found RALDH-1, the rate-limiting enzyme that converts retinaldehyde 
to ATRA, was up-regulated in response to allergic stimulation in the airway epithelium, 
implicating a possible site for the production of ATRA in the lung. Consistent with the 
requirement of ATRA for differentiation of T regulatory cells in vivo25,41,43, we found an 
increase numbers of CD25+ Foxp3+ T cells in the lung of Mmp7−/− mice immunized with 
CAA. Moreover we found that inhibition of retinoic acid synthesis by citral inhibited T 
regulatory cell development. The increased percentage of regulatory T cells following 
allergen challenge in both wild-type and Mmp7−/− mice suggested that RALDH-1 is a 
negative regulator of allergic inflammation, a plausible protective response regulated by 
airway epithelial cells that we found to be enhanced in the absence of MMP7. What remains 
unclear is the mechanism responsible for increased expression and function of RALDH-1 in 
the lung in the absence of MMP7. Our finding of RALDH-1 expression in airway epithelial 
cells and macrophages in response to allergen challenge is in agreement with prior reports 
implicating an anti-inflammatory role for these cells in allergic inflammation44. 
Furthermore, depletion of alveolar macrophages resulted in an exaggerated allergic response 
that could be inhibited by adoptive transfer of alveolar macrophages in Brown Norway 
rats45. Our data suggest that alveolar macrophage mediated anti-inflammatory responses 
during allergic inflammation might be operating through RALDH-1, a concept that is further 
consistent with tolerogenic role of RALDH-1 in gut lamina propria41,42.
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In summary, we have described a pro-inflammatory role of MMP7 that is activated in 
response to proteinase allergens and involves proteolytic modification of IL-25 expression 
and function. In this model, we found activation of RALDH-1 to be downstream of allergen-
induced inflammation and that MMP7 actively inhibits the function of this enzyme in vivo. 
At least in part, this unique mechanism involves inhibition of T regulatory cells that inhibit 
lung inflammation. Our findings thus substantially expand our understanding of the 
regulation of IL-25, a critical innate cytokine in allergic responses, and further identify pro- 
and anti-inflammatory targets that can be explored for therapeutic benefit.
Methods
Mice
Mmp7−/− mice nine generations backcrossed with C57BL/6 were kindly provided by P. Woo 
Park (Children’s Hospital, Harvard School of Medicine), and were bred in the Association 
for Assessment and Accreditation of Laboratory Animal Care (AALAC)-accredited 
transgenic animal facility at Baylor College of Medicine. All experiments were preformed in 
accordance with protocol approved by the Institutional Animal Care and Use Committee at 
Baylor College of Medicine. Mmp7−/− mice were genotyped using standard PCR techniques 
(Neo R: 5′-TTGAGCCTGGCGAACAGT-3′, Neo F: 5′-TGGATTGCACGCAGGTTCT-3′, 
WT F: 5′-ACTTACCTCGGATCGTAGTG-3′, WT R: 5′-
GTCCAGTACTCATCCTTGTC-3′). Wild-type C57BL/6 mice, and/or heterozygote 
littermates were used as controls and were purchased from the Baylor Center for 
Comparative Medicine facility. Stat6−/− mice (BALB/c background) and Il13−/− mice 
(C57BL/6 background) were purchased from Jackson Laboratories and bred 10–12 
generations onto BALB/c background.
Experimental model of asthma
Complete aspergillus allergen (CAA) comprised of 1 mg/ml of Aspergillus oryzae 
proteinase (Sigma) and 0.5 mg/ml of OVA (Sigma) in 50 μl volume, was administered 
intranasally every four days for a total of five times, as described before1,16. In some 
experiments, rIL-25 (5 μg in 50 μl of PBS) were administered intranasally twice daily for 3 
days. In some experiments, liposomal preparation of all transretnoic acid (ATRA) or citral 
was given by aerosol 1 h prior to CAA challenges. Briefly, liposome formulation of ATRA 
(Sigma) and citral (Tokyo Chemical Industry Chemical Co.) were made in 
dilauroylphosphatidylcholine (DLPC) (Avanti Polar Lipid Inc.) as we have previously 
described46. Aerosol was generated from an Aerotech II nebulizer (CIS USA; flow rate 10 
L/Min) and was discharged from an opening to the entry orifice. Following a dose titration 
study that determined efficacy of aerosol delivery, mice received a total concentration of 5 
μg/gram of body weight (approximately 100 μg) of ATRA, 5 mg of citral, or vehicle control 
(empty liposomes) over 1 h before each of the CAA challenges.
Experimental ragweed allergen challenge in human volunteers
Nasal provocation with ragweed pollen extract was performed as previously described47. 
The Institutional Review Board at University of Texas Medical Branch reviewed and 
approved the protocol and consent forms. Briefly, seven otherwise healthy volunteers with 
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symptoms of seasonal allergic rhinitis (congestion, nasal discharge, sneezing) and positive 
prick skin test to ragweed extract were recruited for this study. Volunteers received intranasal 
saline challenges delivered with a nasal spray bottle on one day. On another day, the same 
volunteers received a graded intranasal challenge with ragweed (saline, 0.33, 1, 3, 9, 27 
μg/ml Amb a 1 equivalent in ragweed, (Greer laboratories) every 15 min until sneezing, 
rhinorrhea and nasal congestion were observed47. On both days, 5 ml nasal lavage fluids 
were collected using previously described techniques 30 min and 5 h post nasal challenge. 
The fluids were centrifuged and cell-free supernatants were analyzed for MMP7 response at 
each time point using ELISA (R&D).
Serial sections of bronchial biopsies samples were collected under protocols approved by the 
UCSF Committee on Human Research and with written informed consent for future use as 
part of the UCSF Airway Tissue Bank from five untreated asthmatic and five control 
volunteers were stained for the presence of MMP7 and IL-25 using standard 
immunohistochemical techniques as described below.
Analysis of asthmatic phenotype
All data were collected 24 h following the final allergen challenge. AHR, a pathognomonic 
feature of asthma, was assessed by estimating the provocative concentration of acetylcholine 
in milligrams per gram that causes a 200 percent increase in airway resistance over the 
baseline (PC200) that was calculated by linear interpolation of appropriate dose response 
curves, as described before15. Bronchoalveolar lavage (BAL) fluid was collected by 
instilling and withdrawing 1.6 ml of sterile phosphate buffered saline (PBS) through the 
tracheal cannula in two aliquots of 0.8 ml. BAL fluid total and differential cell count were 
measured using the standard hemocytometer and hematoxylin and eosin (H&E) stain of 
cytospin slides as described previously1. In each experiment, mouse lungs were fixed with 
intra-tracheal instillations of 800 μl of 4% paraformaldehyde solution via a tracheal cannula 
and were embedded in paraffin and 4–5 μm sections of paraffin embedded lung tissues were 
either stained with H&E, periodic acid-Schiff (PAS), and/or were prepared for 
immunohistochemistry.
Immunohistochemistry
Immunohistochemistry was done using the standard protocol described48. Briefly, 
deparaffinized sections were washed with 3% H2O2 and 2% Triton X-100 in PBS (PBST), 
followed by antigen retrieval (Target Retrieval Solution; Dako North America, Inc.). Slides 
were incubated at 4 °C overnight with either rabbit anti-mouse polyclonal antibody against 
ALDH1A1 (Abcam Inc.), rat anti-mouse monoclonal antibody against MMP7 (R&D, Clone 
377314), monoclonal mouse anti-human MMP7 (Calbiochem, Clone ID2), and monoclonal 
mouse anti-human IL-17E in 1:50 to 1:100 dilution, followed by incubation with 
corresponding biotinylated secondary antibodies (1:200 dilution) and Vectastain Elite ABC 
reagent (Vector) at 25 °C. Slides were then incubated with DAB substrate (Vector) and 
counterstained with hematoxylin. After addition of bluing reagent (0.08% NH4OH), slides 
were mounted in xylene.
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BAL Cytokine and Chemokine Measurement
CCL11, CCL7, and CCL17 proteins in BAL fluid were measured using standard antibody 
based ELISA and or BioRad multiplex bead-based cytokine detection kit (BioRad) as 
previously described16. All recombinant protein, capture antibodies, and their corresponding 
biotin-conjugated detection antibodies were purchased from R&D system. IL-4, IL-5, IL-13, 
IL-6 and TNF concentrations in BAL fluid were measured by Lincoplex (Millipore). Equal 
volumes of human nasal washings were used to detect MMP7 using ELISA kit purchased 
from R&D system.
Proteomics analysis of BAL protein
Proteomics analysis of BAL fluid was performed as described previously17. Briefly, BAL 
samples from three mice in each group (wild-type and Mmp7−/−) were pooled and 
concentrated using AMICON filters, and the protein concentration was measured using BCA 
protein assay (Pierce). Equal amount (50 μg) of protein from each pooled sample was 
labeled with 400 pmol of charge and molecular weight matched fluorescent dye CyDye 
(Amersham Biosciences) and brought to a final volume of 250 μl with sample buffer that 
also contained 0.5% ampholytes (3–11 NL), 0.1% bromophenol blue and 12 μl/ml 
DeStreak™ reagent (GE Healthcare). Internal standard was made by mixing equal amounts 
of protein from wild-type and Mmp7−/− samples before CyDye labeling. Wild-type, 
Mmp7−/− and the internal standard (IS) were labeled and loaded for separation on triplicate 
gels as follows: gel 1, WT-Cy3, MMP7−/−Cy5, IS- Cy2; gel 2, WT-Cy5, MMP7−/−Cy3, IS-
Cy2; gel 3, WT-Cy3, KO-Cy5, IS-Cy2. First dimension separation was performed based on 
isoelectric focusing using the GE Healthcare IPGPhor II. The second dimension separation 
was performed using the same IPG strips that were secured in place with agarose on top of a 
15% 18 × 16 cm SDS gel and were electrophoresed for 4 h at 20 mA. Electrophoresed gels 
were scanned using a laser-based image instrument (Typhoon 9400, GE Healthcare) and 
were digitized using ImageQuant software (GE Healthcare). Gel images were imported into 
the DeCyder (v. 5.5) Differential In-gel Analysis (GE Healthcare) program and resulting 
spots were matched among the gels. Using DeCyder Biological Variation Analysis software 
(GE Healthcare), spot differences were quantified and protein spots that exhibited a 
significant normalized change in volume, with respect to the internal standard sample (1.5 
fold; p < 0.05), were picked for identification. For spot picking, spot map coordinates were 
transferred to the ETTAN spot handling work-station (GE Healthcare) for automated 
picking, in-gel trypsin digestion, and MALDI plate spotting.
Quantitative RT-PCR
Total cellular RNA was extracted from RNA Later (Qiagen;) stabilized mouse lung tissues 
using RNeasy mini kit (Qiagen). One step real-time quantitative RT-PCR was used to 
determine the relative expression of Ccl11 (eotaxin-1) and Raldh-1 in Real-Time PCR 
System (7300 Applied Biosystems). The primer and probe mix of target genes, (Ccl11: 
Mm00441238_m1, Raldh-1: Mm01194995_mH) and 18S rRNA were purchased from 
Applied Biosystems. Expression of mRNA samples were normalized to 18S rRNA, and 
relative abundance of the target genes were calculated as described previously16,49. Two-step 
real time q-RT-PCR was performed to determine relative expression of Il25; expression was 
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normalized with Actb. cDNA was generated using oligo-dT, random hexamers, and 
SuperScript RT II (Invitrogen). For real time RT reaction, the following primers were used, 
Il25 primer: 5′-CACACTGCGTCAGCCTACAGA-3′ and 5′-
TGTGGTAAAGTGGGACGGAGTT-3, Actb primer 5′-
GACGGCCAGGTCATCACTATTG-3′ and 5′AGGAAGGCTGGAAAAGAGCC-3′.
MMP activation and in vitro cleavage assay
Carrier-free recombinant mouse 5 μg IL-25 (rIL-25; R&D), mouse recombinant IL-13 
(Peprotech) and mouse recombinant TSLP (R&D) was incubated with 0.5 μg of APMA 
activated MMP7 in the presence or absence of MMP inhibitor, 10 mM 1,10 phenanthroline 
(Sigma) at 37 °C for 2 h. Following incubation, equal volumes of each sample (16.5 μl) were 
reduced and resolved using 16.5% Tricine gel. Cleaved and uncleaved proteins were 
visualized using Proteosilver plus silver stain kit (Sigma-Aldrich) using manufacturer’s 
instructions. Alternatively, cleaved IL-25 protein was separated as above, electroblotted in 
Tris-glycine buffer (25 mM Tris, 192 mM glycine, 10% MeOH (pH 8.3) to a polyvinylidene 
difluoride (PVDF) membrane and stained with 0.05% Coomassie Blue in 1% acetic acid, 
50% methanol. The PVDF membranes were destained in 50% methanol and deionized 
water. The visible bands were cut out with a clean scalpel blade and air-dried, then N-
terminal sequencing of IL-25 was performed using standard protein-sequencing methods 
(Applied Biosystems Procise 492cLC).
Cell culture
Lymph node cells and splenocytes were isolated from C57BL/6 mice and were stimulated 
with 2 μg/ml of plate-bound anti-CD3 and 50 U/ml of human IL-2 in the presence of 250 
ng/ml of mouse rIL-25 (R&D) or 250 ng/ml of MMP7 cleaved mouse rIL-25 (IL-25′C). 
After 2 days, culture supernatants were collected and analyzed for IL-4, IL-5, IL-13 and 
IFN-γ by ELISA as described previously5. On day 3, cells were restimulated with 500 ng/ml 
ionomycin and 50 ng/ml PMA in the presence of GolgiStop (BD Biosciences) for 5 h. Cells 
were permeabilized with a Cytofix/Cytoperm kit (BD Biosciences) and analyzed for the 
intracellular expression of IL-4 (PE conjugated) and IL-5 (APC conjugated) (BD 
biosciences, Clone 11B11 and TRFK5 respectively).
Flow cytometry
Total lung eosinophil numbers were quantified using beads enhanced flow cytometry 
method as described previously50. Briefly, total murine lung cells were stained with MHC-II 
(FITC conjugated), SiglecF (PE conjugated) (1 μg/106 cells) (BD Biosciences, Clone 
E50-2440), followed by incubation with Fluorescent beads (Flow-Check™ Fluorospheres, 
Beckman Coulter). Samples were acquired in flow cytometer (XL2, Beckman Coulter Inc.); 
cell and bead counts were measured. Absolute numbers of eosinophils were calculated using 
formulas as described previously50. Abundance of lung T regulatory cells was estimated by 
staining the cells with Mouse Regulatory T cell Staining Kit (eBioscience); samples were 
acquired in BD LSRII flow cytometer. Analysis was performed with FlowJo software 
(version 8.5.3).
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High Performance Liquid Chromatography (HPLC)
Pooled BAL samples from WT and Mmp7−/− mice were evaporated under N2 and the dry 
residue was dissolved in 100 μl of acetonitrile (Fisher). Aliquots of 25 μl were subsequently 
analyzed by Waters HPLC system consisting of WISP autosampler (model 717 plus), Dual 
Absorbance detector (model 2487), Pump (model 515) and Nova pak C-18 columns 
(3.9×150mm). Separation of ATRA was performed using a solvent system composed of 
57.5% acetonitrile, 25% of 2% of acetic acid at a flow rate of 1.3 ml/min. Data was analyzed 
in Waters Millennium software (version 3.2).
IL-25-IL-17RB-Fc binding assay
Recombinant mouse IL-17RB-Fc fusion protein (R&D Systems) or PBS was used to coat 
96-microtiter plates. After blocking, recombinant mouse IL-25 or MMP7 cleaved IL-25 
(IL-25′C) was added at different concentrations (100 pg/ml to 50,000 pg/ml). After 
washing, biotinylated anti-mouse IL-25 antibody (R&D Systems) was added and the ability 
of recombinant IL-25 or IL-25′C to bind to IL-17RB-Fc fusion protein was detected by 
using standard ELISA protocol.
Statistics
All data are representative of at least 3 independent experiments with 4–5 mice in each in 
vivo experiment and are expressed as means ± SEM and were analyzed using Prism 4.0a 
statistical analysis software. We used t-test, one-way analysis of variance (ANOVA) and 
Bonferroni multiple comparison tests to identify significant differences (P < 0.05) between 
treatment groups.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. MMP7 is induced in allergic inflammation and modulates IL-25 function
(a) Detection of MMP7 in lung of PBS treated (C57BL/6), and mice immunized with CAA 
by immunohistochemistry (arrows indicate MMP-7 expression; insets show 40× 
magnification of airway). Bars indicate 100 μm and 25 μm bar. (b) Recombinant (r)IL-25 (5 
μg), rIL-13 (5 μg) and rTSLP (5 μg) were incubated for 2 h at 37 °C with APMA-activated 
MMP7 (0.5 μg), and were resolved on 16.5% Tricine gel followed by detection using silver 
stain (arrows indicate bands corresponding to fragments of rIL-25 that were cleaved by 
MMP7). (c) Naïve lymph node cells (left) and spleen cells (right) isolated from C57BL/6 
mice, were stimulated with 2 μg/ml of plate-bound anti-CD3 in the presence of equal 
amount of native rIL-25 (250 ng/ml) or MMP7 cleaved rIL-25 (IL-25′C; 250 ng/ml). On day 
2, cell culture-supernatants from each condition were examined for the concentration of 
IL-4, IL-5, IL-13 and IFN-γ by ELISA. Media alone and APMA containing buffer that was 
used to activate MMP-7 (vehicle) were used as controls (n=3; data represent mean values ± 
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SD; representative of three different experiments).*P< 0.05 relative to rIL-25, using the one-
way ANOVA test. (d) Representative flow cytometry data of lymphocytes, following three 
days of culture under the same conditions as described in (c). Cells were restimulated with 
500 ng/ml ionomycin and 50 ng/ml PMA in the presence of GolgiStop for 5 h, and the 
percentage of cells expressing IL-4 and IL-5 were detected by intracytoplasmic staining. 
Data is representative of 3 independent experiments.
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Figure 2. MMP-7 null mice show reduced asthma phenotype
Age and sex matched wild-type (WT), (n = 4) and Mmp7−/− mice (n = 4) were immunized 
intranasally with CAA or PBS for every 4 days for a total of five times and 24 h after the last 
immunization, mice were assessed for (a,b) AHR is shown as dose response curve to 
acetylcholine and using PC 200, and (c) Glycoproteins in BAL detected by ELISA. (d) 
Eosinophil cell counts from BAL were determined from the same groups of mice. *P < 0.05 
relative to PBS challenged WT and **P < 0.05 relative to CAA immunized WT mice using 
one way ANOVA and t-test. Data represent mean values ± SD (e) Representative 
photomicrographs of bronchovascular bundles (n=4 per group) stained with H&E. Bar 
indicates 100 μm. (f,g) WT and MMP7 null mice were given intranasal PBS or rIL-25 (5 μg) 
twice daily for 3 days, and 24 h following the last dose, total cell and eosinophil count (f) 
and IL-4, and IL-5 (g) were assessed in the BAL fluid. (Data represent mean values ± SD; 
representative of 3 independent experiments; n=4 per group; *P < 0.05 relative to WT mice 
treated with rIL-25).
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Figure 3. Attenuated TH2 cytokines and chemokines in Mmp7−/− mice
Mmp7−/− mice and age and sex matched wild-type (n=5 per group) mice immunized as 
described in Fig. 2 and 24 h after the last immunization, concentrations of (a) IL-4, (b) IL-5 
and (c) IL-13 were measured in BAL fluid using Luminex. (d) Level of CCL11 in BAL fluid 
was measured by ELISA. (e) Expression of Il-25 mRNA in the lung of WT and Mmp7−/− 
CAA immunized mice was measured by real time RT-PCR. Data was normalized to actin. 
(Data represent mean values ± SD; representative of 3 independent experiments). *P < 0.05 
relative to PBS challenged WT and **P < 0.05 relative to CAA immunized WT mice using 
one way ANOVA and t-test.
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Figure 4. Proteomics analysis of BAL fluid of WT and Mmp7−/− CAA immunized mice
(a) Two-dimensional gel electrophoresis of pooled BAL fluid from wild-type (WT) (green, 
Cy 3) and Mmp7−/− (red, Cy 5) CAA immunized mice reveals differential processing of 
proteins (see Supplementary Table 2; n = 3 in each group) two independent experiments. 
Super-imposed green and red images highlight differences between WT and Mmp7−/− BAL 
proteins. Yellow indicates no change, red spots were more abundant in knockout, and green 
spots were more abundant in WT. Arrow indicated the location and abundance of Retinal 
dehydrogenase-1 (RALDH-1) protein in WT and Mmp7−/− CAA immunized mice. (b) Spot 
volumes were standardized and log transformed using DeCyder software, Biological 
Variation Analysis. Each point represents the spot volume from a pooled sample (n = 3), and 
graphically is shown as the mean value of RALDH-1 abundance. Data represent mean 
values ± SD; *P < 0.05 relative to saline challenged WT and **P < 0.05 relative to CAA 
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immunized WT mice using t-test. (c) Representative chromatogram of ATRA absorbance 
unit (AU) in the BAL fluid (n = 3) as determined using HPLC) in WT and Mmp7−/− mice 
immunized with CAA or PBS (control) (Left, WT PBS control), middle, WT, and right 
panel Mmp7−/− mice immunized with CAA). (d) Total BAL cell count, (e) eosinophil cell 
count recovered from WT mice that were treated with liposomal ATRA (5 μg/grams body 
weight) 1 h before intranasal CAA immunization. Negative control group (PBS, liposomal 
ATRA; n = 5) and positive control group (CAA; n = 5) were used. Same groups of mice 
were used to measure (f) Il-25, and (g) Ccl11 mRNA expression in the lungs by real time 
RT-PCR, expression was normalized to actin and 18S respectively. (h) IL-4 and (i) IL-13 
levels in BAL fluid were measured by Luminex. (Data represent mean values ± SD; 
representative of 3 independent experiments. *P < 0.05 relative to PBS challenged WT and 
**P < 0.05 relative to CAA immunized WT mice using one-way ANOVA test).
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Figure 5. Epithelial expression of RALDH-1 in response to allergens initiates a negative 
regulatory response
a) RALDH-1 expression was detected using immune histochemistry in lung sections of WT 
and Mmp7−/− mice immunized intranasally with CAA or PBS (arrows indicate RALDH-1 
expression; representative of two independent experiments). b) Representative flow figures 
show the abundance of T regulatory cells in lungs of WT and MMP7 null CAA or sham 
(PBS) immunized mice that were stained with anti-CD4, -CD25 and -FoxP3 (n=4 in each 
group, two independent experiments). Abundance of T regulatory cells were also determined 
from WT and Mmp7−/− mice that were given citral, 1 hour before CAA immunization. 
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Intranasal administration of the same concentration of CAA was used controls. c) Total cell 
count, d) Eosinophil count, and e) IL-5 concentration in the BAL of mice treated in 
experimental conditions described in (b). Intranasal administration of citral and CAA were 
used as negative and positive controls respectively. (n=4 mice per group; data represent 
mean values ± SD; representative of 3 independent experiments. *P< 0.05 relative to CAA 
challenged WT and **P< 0.05 relative to CAA challenged MMP7 null mice using t-test).
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Figure 6. MMP7 and IL-25 expression in human asthma
a) Representative serial photomicrograph of human bronchial biopsies samples from a non-
asthmatic (top panels) and an asthmatic (bottom panels) individual, stained with anti-MMP7 
(left panels) or anti-IL-25 (right panels). Arrows point to positive immunoreactivity and 
arrowhead shows negative expression of MMP7 in non-asthmatic airway. Data represent 
mean values ± SD; n=5 in each group. b) Nasal washings obtained from seven atopic/
allergic volunteers challenged with graded ragweed (RW) or saline (data not shown) 
intranasaly (see methods for detail), were used to detect MMP7 responses at each time point 
using ELISA (R&D). *P< 0.05 relative to 30min challenged RW using two-tailed paired t-
test
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